IL6R and cervical squamous intraepithelial neoplasia: In addition, tocilizumab treatment largely reduced the viability of primary cell cultures with high IL-6/IL-6R expression, which were derived from genetically engineered mouse model of CIN-induced acute T-cell lymphoma.